Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
BMJ (Clinical Research Ed.)|February 22, 2005
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trialClive Ballard, Marisa Margallo-Lana, Edmund Juszczak, et al.
Redox Biology|June 2, 2019
HDL subclass proteomic analysis and functional implication of protein dynamic change during HDL maturationYuling Zhang, Scott M Gordon, Hang Xi, et al.
Journal of Psychopharmacology (Oxford, England)|January 21, 2017
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for PsychopharmacologyJohn T O'Brien, Clive Holmes, Matthew Jones, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 26, 2022
Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsyLeonidas Chouliaras, Alan Thomas, Maura Malpetti, et al.
Journal of the International Neuropsychological Society : JINS|October 20, 2021
Neuropsychological Impairments and Their Cognitive Architecture in Mild Cognitive Impairment (MCI) with Lewy Bodies and MCI-Alzheimer's DiseaseJoanna Ciafone, Alan Thomas, Rory Durcan, et al.
Journal of Alzheimer'S Disease : JAD|August 12, 2017
PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid BiomarkersIvan Koychev, Roger N Gunn, Azadeh Firouzian, et al.
Nature Genetics|December 13, 2006
Genome variation and evolution of the malaria parasite Plasmodium falciparumDaniel C Jeffares, Arnab Pain, Andrew Berry, et al.
Pageof 11